Ono Pharmaceutical (OPHLY) News Today $3.46 +0.04 (+1.17%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X InstituteSeptember 17, 2024 | finance.yahoo.comOno Pharmaceutical Co. Ltd. ADRAugust 6, 2024 | wsj.comONO PHARMACEUTICAL earnings: here's what Wall Street expectsJuly 30, 2024 | markets.businessinsider.comOno Pharmaceutical is about to announce its earnings — here's what to expectMay 8, 2024 | markets.businessinsider.comJapan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansionApril 30, 2024 | reuters.comDeciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 BillionApril 29, 2024 | msn.comDeciphera Pharmaceuticals Gets $2.4B Buyout Offer From ONO PharmaceuticalApril 29, 2024 | marketwatch.comONO To Acquire Deciphera; Total Equity Value Of Deal At Approx. $2.4 BlnApril 29, 2024 | markets.businessinsider.comJapan's ONO Pharmaceutical to buy Deciphera for $2.4 billionApril 29, 2024 | reuters.comOno signs licence deal with NEX-I for cancer therapyMarch 6, 2024 | msn.comFate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 26, 2024 | finance.yahoo.comInveniAI Announces Collaboration with Ono Pharmaceutical for Target DiscoveryFebruary 19, 2024 | markets.businessinsider.comOno Pharmaceutical Co., Ltd. (OPHLY)February 15, 2024 | finance.yahoo.comNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of CancerFebruary 14, 2024 | globenewswire.comOno Pharmaceutical Co. Ltd.February 10, 2024 | barrons.comOno Pharmaceutical earnings preview: what Wall Street is expectingJanuary 30, 2024 | markets.businessinsider.comCall for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed XJanuary 9, 2024 | finance.yahoo.comThe BioMed X Institute: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer ResearchDecember 19, 2023 | finanznachrichten.deNikkei Edges 0.2% Lower Amid JPY StrengthNovember 28, 2023 | finance.yahoo.comChina Shares Open Lower; Infrastructure Stocks WeighNovember 27, 2023 | finance.yahoo.comOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 10.78% to 7.59October 5, 2023 | msn.comTwist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune DiseasesAugust 31, 2023 | finance.yahoo.comTwist Bioscience To Develop Novel Antibodies With Ono PharmaAugust 31, 2023 | markets.businessinsider.comQ2 2023 Fate Therapeutics Inc Earnings CallAugust 9, 2023 | finance.yahoo.comOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Decreased by 29.33% to 6.89August 3, 2023 | msn.comMacomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of CancerMarch 23, 2023 | technews.tmcnet.comMemo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology TargetsNovember 1, 2022 | benzinga.com3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth StockSeptember 19, 2022 | finance.yahoo.comFate Therapeutics: Yes For Speculators, No For Defensive InvestorsAugust 30, 2022 | seekingalpha.comOno Pharmaceutical (OTC:OPHLY), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comOno Pharmaceutical (OTC:OPHLY), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comCan Ono Pharmaceutical Co ride out the impact of economic shocks?July 7, 2022 | uk.finance.yahoo.comOno Pharmaceutical Co. Ltd ADR (OPHLY)January 23, 2022 | nasdaq.comHere's what to expect from ONO PHARMACEUTICAL's earnings reportNovember 8, 2021 | markets.businessinsider.com Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address OPHLY Media Mentions By Week OPHLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHLY News Sentiment▼0.000.60▲Average Medical News Sentiment OPHLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHLY Articles This Week▼00▲OPHLY Articles Average Week Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZNCF News CMOPF News JCRRF News KYKOF News MAYNF News OTSKF News RHHVF News SNYNF News SCLXW News VRBCF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OPHLY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ono Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
